• | 6.9C United States of America

Author Login

Forgot Password?
|  
  • About AIV
  • Editors
    • Editorial-Board
    • Editor-in-Chief
  • Articles
    • Recent Articles
  • Authors
    • Author Guidelines
    • Reviewer Guidelines
    • Editor Guidelines
  • Submission
  • Contact Us
  • About AIV
  • Editors
    • Editorial-Board
    • Editor-in-Chief
  • Articles
    • Recent Articles
  • Authors
    • Author Guidelines
    • Reviewer Guidelines
    • Editor Guidelines
  • Submission
  • Contact Us

Advances in Vaccines

Advances in Vaccines is freely accessible to all the readers throughout the world without any subscription charges. Articles can be reused or redistributed by the authors without restriction, unless the original work is correctly cited. Advances in Vaccines is Scientific and Scholarly Publisher that affiliates the Open Access Publications to make science widely available and benefit the scientific field by Scholarly articles subject to high level peer review by eminent scientists. We follow ethical policies & standards to ensure high quality scientific works and are freely accessible online.


View Journal Scope   Volume 2025

Open Access
Journal

Popular Keywords

Vaccine Development & Technologies

mRNA vaccines

DNA vaccines

Recombinant vaccines

Viral vector vaccines

Live attenuated vaccines

SUBMIT MANUSCRIPT HERE

JOIN EDITORIAL-BOARD

PROPOSE SPECIAL ISSUE

Recent Articles

Covid-19 Vaccine-Induced Chronic False Positive Rapid Plasma Reagin (Rpr) Tests.

  • case Report
  • Open Access
  • Davita Pav
PDF FullText DOI: 10.52338/aiv.2025.1005

Developments And Difficulties Of Messenger Rna Vaccines In Nsclc Therapy.

  • Review Article
  • Open Access
  • Etycha Kioui
PDF FullText DOI: 10.52338/aiv.2025.1004

Monitoring of Non-Vaccinated Chickens for Avian Metapneumovirus and Co-Infection with Avian Pathogenic Escherichia coli.

  • Research Article
  • Open Access
  • Carvalho Sales
PDF FullText DOI: 10.52338/aiv.2025.1003

Reducing Cholera Mortality and Incidence: Unfinished Business

  • Editorial
  • Open Access
  • Dad Naln
PDF FullText DOI: 10.52338/aiv.2025.1002

The Resurgence Of Measles In Europe: A Significant Development In The Study Of Vaccine-Preventable Illnesses.

  • Editorial
  • Open Access
  • Antoni De Frances
PDF FullText DOI: 10.52338/aiv.2025.1001

Journal Info

  • Journal Name: Advances in Vaccines
  • DOI: 10.52338/aiv
  • Short Name: AIV
  • Acceptance rate: 75%
  • Volume: 1 (2025)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility

Advances in Vaccines

Open Access Journal

Advances in Vaccines, is a peer review, and open access that gives doctors, scientists, and medical researchers from all backgrounds a place to publish original high quality research articles, clinical case studies, procedural videos, clinical images, and brief videos on ongoing clinical research.

Contact Us

Address: 30 N Gould ST STE R Sheridan, WY 82801 USA

Email: contact@directivepublications.org

Website: directivepublications.org

Quick Links

  • Author Instructions
  • Submit Manuscript
  • Open Access Policy
  • Sitemap
  • Contact

Special Issues

Nanoparticle-based vaccines Adaptive immunity T-cell response Pathogenic Fungi B-cell activation Adjuvants

Copyrights © 2025 All Rights Reserved by Advances in Vaccines

Contact Us Privacy Policy